Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen : Why, who and how long?KAUFMANN, Manfred; RODY, Achim.European journal of obstetrics, gynecology, and reproductive biology. 2006, Vol 126, Num 2, pp 146-154, issn 0301-2115, 9 p.Article

Long-term risk of breast cancer recurrence : the need for extended adjuvant therapyKAUFMANN, Manfred; RODY, Achim.Journal of cancer research and clinical oncology. 2005, Vol 131, Num 8, pp 487-494, issn 0171-5216, 8 p.Article

Development of the mechanical stability of a restored soil during the first 3 years of re-cultivationKAUFMANN, Manfred; TOBIAS, Silvia; SCHULIN, Rainer et al.Soil & tillage research. 2009, Vol 103, Num 1, pp 127-136, issn 0167-1987, 10 p.Article

Quality evaluation of restored soils with a fuzzy logic expert systemKAUFMANN, Manfred; TOBIAS, Silvia; SCHULIN, Rainer et al.Geoderma (Amsterdam). 2009, Vol 151, Num 3-4, pp 290-302, issn 0016-7061, 13 p.Article

Use of Standard Markers and Incorporation of Molecular Markers Into Breast Cancer Therapy: Consensus Recommendations From an International Expert PanelKAUFMANN, Manfred; PUSZTAI, Lajos.Cancer. 2011, Vol 117, Num 8, pp 1575-1582, issn 0008-543X, 8 p.Article

Use of goserelin in the treatment of breast cancerRODY, Achim; LOIBL, Sibylle; VON MINCKWITZ, Gunter et al.Expert review of anticancer therapy. 2005, Vol 5, Num 4, pp 591-604, issn 1473-7140, 14 p.Article

Locoregional Treatment of Primary Breast Cancer: Consensus Recommendations From an International Expert PanelKAUFMANN, Manfred; MORROW, Monica; VON MINCKWITZ, Gunter et al.Cancer. 2010, Vol 116, Num 5, pp 1184-1191, issn 0008-543X, 8 p.Article

Neoadjuvant breast cancer therapy : the German experienceVON MINCKWITZ, Gunter; LOIBL, Sibylle; KAUFMANN, Manfred et al.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 2, pp 4-9, issn 1359-6349, 6 p.Conference Paper

Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferationJUPING YUAN; KRÄMER, Andrea; ECKERDT, Frank et al.Cancer research (Baltimore). 2002, Vol 62, Num 15, pp 4186-4190, issn 0008-5472Article

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk FactorsFILIPITS, Martin; RUDAS, Margaretha; FREIBAUER, Christa et al.Clinical cancer research (Print). 2011, Vol 17, Num 18, pp 6012-6020, issn 1078-0432, 9 p.Article

The GISS Trial: a Phase II Prevention Trial of Screening Plus Goserelin, Ibandronate, versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerVON MINCKWITZ, Gunter; LOIBL, Sibylle; VESCIA, Sabine et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 10, pp 2141-2149, issn 1055-9965, 9 p.Article

Ceramide synthases and ceramide levels are increased in breast cancer tissueSCHIFFMANN, Susanne; SANDNER, Jessica; GEISSLINGER, Gerd et al.Carcinogenesis (New York. Print). 2009, Vol 30, Num 5, pp 745-752, issn 0143-3334, 8 p.Article

Clinical response by palpation during primary systemic therapy with four dose-dense cycles doxorubicin and docetaxel in patients with operable breast cancer : Further results from a randomised controlled trialMÜLLER, Christine; CAPUTO, Angelika; SCHUMACHER, Martin et al.European journal of cancer (1990). 2007, Vol 43, Num 11, pp 1654-1661, issn 0959-8049, 8 p.Article

C-KIT expression in ductal carcinoma in situ of the breast : co-expression with HER-2/neuDIALLO, Raihanatou; RODY, Achim; GABBERT, Helmut E et al.Human pathology. 2006, Vol 37, Num 2, pp 205-211, issn 0046-8177, 7 p.Article

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer : An updateKAUFMANN, Manfred; HORTOBAGYI, Gabriel N; LEBEAU, Annette et al.Journal of clinical oncology. 2006, Vol 24, Num 12, pp 1940-1949, issn 0732-183X, 10 p.Article

Osteoporosis case finding in the general practice : phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometryGASSER, Katharina M; MUELLER, Christian; ZWAHLEN, Marcel et al.Osteoporosis international. 2005, Vol 16, Num 11, pp 1353-1362, issn 0937-941X, 10 p.Article

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer SubtypesVON MINCKWITZ, Gunter; UNTCH, Michael; JACKISCH, Christian et al.Journal of clinical oncology. 2012, Vol 30, Num 15, pp 1796-1804, issn 0732-183X, 9 p.Article

Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio StudyVON MINCKWITZ, Gunter; KÜMMEL, Sherko; LOIBL, Sibylle et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 8, pp 552-562, issn 0027-8874, 11 p.Article

Neoadjuvant Vinorelbine-Capecitabine Versus Docetaxel-Doxorubicin-Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio TrialVON MINCKWITZ, Gunter; KÜMMEL, Sherko; LOIBL, Sibylle et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 8, pp 542-551, issn 0027-8874, 10 p.Article

Poor outcome in estrogen receptor-positive breast cancers predicted by loss of Plexin B1RODY, Achim; HOLTRICH, Uwe; AHR, Andre et al.Clinical cancer research. 2007, Vol 13, Num 4, pp 1115-1122, issn 1078-0432, 8 p.Article

A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer : GABG-IV B-93KAUFMANN, Manfred; GRAF, Erika; VON MINCKWITZ, Gunter et al.European journal of cancer (1990). 2007, Vol 43, Num 16, pp 2351-2358, issn 0959-8049, 8 p.Article

Characterization of WNT7A expression in human endometrium and endometriotic lesionsGAETJE, Regine; HOLTRICH, Uwe; KARN, Thomas et al.Fertility and sterility. 2007, Vol 88, Num 6, pp 1534-1540, issn 0015-0282, 7 p.Article

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients : A randomised trial (GABG trial IV-A-93)VON MINCKWITZ, Gunter; GRAF, Erika; KAUFMANN, Manfred et al.European journal of cancer (1990). 2006, Vol 42, Num 12, pp 1780-1788, issn 0959-8049, 9 p.Article

Cancer of the uterine cervix is susceptible to anti-EGF-R antibody EMD 55,900 therapySOLBACH, Christine; ROLLER, Marc; NICOLETTI, Maria et al.Anticancer research. 2005, Vol 25, Num 6B, pp 4261-4267, issn 0250-7005, 7 p.Article

Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancerSULBACH, Christine; ROLLER, Marc; AHR, Andre et al.International journal of cancer. 2002, Vol 101, Num 4, pp 390-394, issn 0020-7136, 5 p.Article